Chia Tai Enterprises International Limited (HK:3839)
:3839
Want to see HK:3839 full AI Analyst Report?
3839 Stock Chart & Stats
HK$6.79
HK$0.07(4.61%)
At close: 4:00 PM EST
HK$6.79
HK$0.07(4.61%)
Day’s Range― - ―
52-Week RangeHK$1.74 - HK$10.15
Previous CloseN/A
Volume9.50K
Average Volume (3M)166.49K
Market Cap
HK$2.14B
Enterprise ValueHK$279.41M
Total Cash (Recent Filing)HK$35.49M
Total Debt (Recent Filing)HK$59.09M
Price to Earnings (P/E)9.6
Beta1.47
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding240,718,300
10 Day Avg. Volume121,886
30 Day Avg. Volume166,494
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.85
Price to Sales (P/S)0.44
P/FCF Ratio8.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative, Improving LeverageDebt-to-equity falling to ~0.17 in 2025 with equity growth materially improves financial resilience. Lower leverage increases flexibility for capex, working-capital cycles and adverse shocks, reducing refinancing risk and supporting durable operations and strategic choices over the next 2–6 months.
Sharp Revenue ReboundA ~2.6x revenue jump into 2025 and ~74% revenue growth indicate a meaningful demand recovery and scale effect. Sustained top-line expansion can absorb fixed costs, support margin recovery and underpin medium-term cash generation, improving durability of earnings and investment capacity.
Improved Operating And Free Cash FlowPositive operating cash flow and FCF (~28m) with FCF covering ~82% of net income show materially better earnings quality and internal funding. This improved cash conversion supports reinvestment, debt reduction or shareholder returns and strengthens medium-term financial flexibility.
Bears Say
Volatile Profitability And Margin ErosionSignificant margin compression from historical gross margins (~24–27% earlier to ~14% in 2025) and prior negative net income highlight structural pressure on pricing or costs. Persistent margin erosion would limit sustainable profitability and ROE, constraining resilience beyond short-term rebounds.
Historically Uneven Cash ConversionDespite 2025 improvements, recurring periods of negative operating or free cash flow show unstable cash conversion. That inconsistency raises the risk of liquidity pressure during downturns, limiting the company's ability to fund growth or absorb shocks without external financing.
Concentration In Antibiotic Animal ProductsBusiness concentration in chlortetracycline and antibiotic-based animal health creates product and end-market dependency. This narrow exposure raises structural risk from demand shifts, regulatory tightening on antibiotic use, or competitive disruption that could materially affect revenue and margins.
Chia Tai Enterprises International News
3839 FAQ
What was Chia Tai Enterprises International Limited’s price range in the past 12 months?
Chia Tai Enterprises International Limited lowest stock price was HK$1.74 and its highest was HK$10.15 in the past 12 months.
What is Chia Tai Enterprises International Limited’s market cap?
Chia Tai Enterprises International Limited’s market cap is HK$2.14B.
When is Chia Tai Enterprises International Limited’s upcoming earnings report date?
Chia Tai Enterprises International Limited’s upcoming earnings report date is Aug 07, 2026 which is in 75 days.
How were Chia Tai Enterprises International Limited’s earnings last quarter?
Chia Tai Enterprises International Limited released its earnings results on May 12, 2026. The company reported HK$0.174 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.174.
Is Chia Tai Enterprises International Limited overvalued?
According to Wall Street analysts Chia Tai Enterprises International Limited’s price is currently Overvalued.
Does Chia Tai Enterprises International Limited pay dividends?
Chia Tai Enterprises International Limited does not currently pay dividends.
What is Chia Tai Enterprises International Limited’s EPS estimate?
Chia Tai Enterprises International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chia Tai Enterprises International Limited have?
Chia Tai Enterprises International Limited has 240,718,300 shares outstanding.
What happened to Chia Tai Enterprises International Limited’s price movement after its last earnings report?
Chia Tai Enterprises International Limited reported an EPS of HK$0.174 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.292%.
Which hedge fund is a major shareholder of Chia Tai Enterprises International Limited?
Currently, no hedge funds are holding shares in HK:3839
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Chia Tai Enterprises International Limited
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.
Technical Analysis
The United Laboratories International Holdings
―
China Traditional Chinese Medicine Holdings Co
―
Wai Yuen Tong Medicine Holdings Limited
―
Lee's Pharmaceutical Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---